Literature DB >> 21686672

Peripheral neuropathy in chromosome16q22.1 linked autosomal dominant cerebellar ataxia.

Yoshiko Furiya1, Makito Hirano, Masami Nomura, Hidehiro Asai, Takao Kiriyama, Satoshi Ueno.   

Abstract

Autosomal dominant cerebellar ataxia (ADCA) includes heterogeneous neurodegenerative diseases with or without various neurological signs and symptoms. Ishikawa et al reported a new type of ADCA, named chromosome16q22.1 linked ADCA (16q-ADCA), attributed to a heterozygous C→T substitution in the 5' non-coding region of puratrophin-1 gene. We searched for this mutation in168 patients from 129 families with ADCA and found it in six patients. The patients generally showed late onset pure cerebellar ataxia similar to previous reports but two had mild axonal neuropathy and orthostatic hypotension (OH). Our results suggest that 16q-ADCA shows a broader clinical presentation than previously thought.

Entities:  

Year:  2009        PMID: 21686672      PMCID: PMC3029607          DOI: 10.1136/bcr.08.2008.0707

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  A clinical, genetic, and neuropathologic study in a family with 16q-linked ADCA type III.

Authors:  K Owada; K Ishikawa; S Toru; G Ishida; M Gomyoda; O Tao; Y Noguchi; K Kitamura; I Kondo; E Noguchi; T Arinami; H Mizusawa
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains.

Authors:  Kinya Ishikawa; Shuta Toru; Taiji Tsunemi; Mingshun Li; Kazuhiro Kobayashi; Takanori Yokota; Takeshi Amino; Kiyoshi Owada; Hiroto Fujigasaki; Masaki Sakamoto; Hiroyuki Tomimitsu; Minoru Takashima; Jiro Kumagai; Yoshihiro Noguchi; Yoshiyuki Kawashima; Norio Ohkoshi; Gen Ishida; Manabu Gomyoda; Mari Yoshida; Yoshio Hashizume; Yuko Saito; Shigeo Murayama; Hiroshi Yamanouchi; Toshio Mizutani; Ikuko Kondo; Tatsushi Toda; Hidehiro Mizusawa
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

3.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.

Authors:  P Trouillas; T Takayanagi; M Hallett; R D Currier; S H Subramony; K Wessel; A Bryer; H C Diener; S Massaquoi; C M Gomez; P Coutinho; M Ben Hamida; G Campanella; A Filla; L Schut; D Timann; J Honnorat; N Nighoghossian; B Manyam
Journal:  J Neurol Sci       Date:  1997-02-12       Impact factor: 3.181

Review 4.  The wide spectrum of spinocerebellar ataxias (SCAs).

Authors:  Mario-Ubaldo Manto
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

5.  Peripheral nerve involvement in spinocerebellar ataxias.

Authors:  Bart P C van de Warrenburg; Nicolette C Notermans; Helenius J Schelhaas; Nens van Alfen; Richard J Sinke; Nine V A M Knoers; Machiel J Zwarts; Berry P H Kremer
Journal:  Arch Neurol       Date:  2004-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.